Interstitial lung disease appears to be a risk factor for radiation pneumonitis, a potentially life-threatening adverse effect of radiotherapy to the chest and thorax.
[Cancer Management and Research] Secondary cancer risk following radiotherapy is an increasingly important topic in clinical oncology with impact on treatment decision making and on patient management.
Radiogenomics is maturing into a predictor of patients' likelihood of experiencing radiotoxicities and late radiation effects.
Psychosocial decline occurs in an estimated one-third of patients undergoing radiotherapy for cancer. These declines may sometimes be ameliorated by vigilant recognition of the need to refer patients for psychosocial support interventions.
High-dose-rate (HDR) brachytherapy is typically used as a dose-escalating boost for external beam radiotherapy for prostate cancer; however, some researchers believe it might be close to graduating to a viable monotherapy.
Some patients undergoing radiotherapy for cancers of the head, neck, and brain are at risk for endocrinopathies. This article reviews the risks, detection, and management of radiotherapy-induced hypopituitarism.
What is the best approach to learning more about the field of Radiation Oncology?
Is there a difference in dosing (1 hour prior to radiotherapy vs bedtime) with temozolomide plus radiotherapy for glioblastoma multiforme?
Is combination therapy of imatinib (Gleevec) and radiotherapy safe?
Sexual dysfunction is a common and distressing side effect of prostate cancer treatment. Two new reports from randomized clinical trials offer mixed results for adjuvant pharmacotherapy intended to prevent erectile dysfunction in men undergoing radiotherapy for prostate cancer.
Present barriers for the usual dosimetry accompanying photodynamic therapy (PDT) for late-stage pancreatic cancer can be overcome via clinical technologies.
EPO plus radiotherapy does not improve local-regional control in anemic patients with head and neck cancer
Combination erythropoietin and radiation therapy did not improve control for anemic patients with head and neck squamous cell carcinoma.
A gap exists between patient expectations and current practices for provision of information about radiation use.
New evidence indicates that combining chemotherapy with radiation therapy may be the best option for people with a low-grade form of brain cancer.
Patients with cancer desire more information from health care professionals about medical imaging tests that use radiation.
Treating metastatic melanoma with a combination of radiotherapy and two immunotherapies that target the CTLA4 and PD-1 pathways could produce an optimal response in more patients.
The use of 3D printing to construct devices of varied sizes and shapes could become a powerful tool in customizing interventional radiology treatments to individual patient needs.
A recent study has determined that radiation therapy is the most common treatment for prostate cancer regardless of cancer stage, PSA level, or prognosis and risk rating.
Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy are advised to receive more aggressive radiation therapy treatment, according to a study.
More than a third of women who should receive radiation subsequent to mastectomy are actually undergoing the recommended postmastectomy radiation therapy (PMRT), according to a new study.
- Vitamin D and prostate cancer: Higher intake improves active surveillance outcomes
- Triple combination of two targeted therapies + immunotherapy is more effective in advanced melanoma
- Muscle-building supplements may be associated with testicular cancer
- Promising drug target identified in medulloblastoma
- Physical activity associated with less chemo-induced peripheral neuropathy
- mHealth app assesses breast cancer risk and aids prevention
- Socioeconomic factors increase mortality after lung cancer surgery
- Half of older U.S. adults take aspirin as preventive medicine
- Cardiorespiratory fitness linked with decreased metabolic syndrome risk among smokers
- Adjuvant chemotherapy in non-small cell lung cancer: State-of-the-art
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|